盤龍藥業(002864.SZ):蘇州永樂九鼎等已減持2.05%的股份
格隆匯6月5日丨盤龍藥業(002864.SZ)公佈,近日,公司收到蘇州永樂九鼎、天樞鐘山九鼎、春秋晉文九鼎、春秋齊桓九鼎、春秋楚莊九鼎出具的《關於股份減持計劃進展情況的告知函》,彼等已合計減持177.6883萬股,減持比例2.05%。
公司於2020年5月12日披露了《關於持股5%以上股東及其一致行動人股份減持計劃提前終止暨未來減持計劃的預披露公告》,在遵守相關法律規定的前提下,彼等擬通過集中競價、大宗交易、協議轉讓等方式,結合市場情況進行減持,減持比例不設限制。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.